Previous Hold Today AGRX ranks #1181 as HOLD CANDIDATE. Next Hold
Today AGRX ranks #1181 as HOLD CANDIDATE.

AGRX stock Agile Therapeutics

AGRX stock
Agile Therapeutics

March 22, 2019
Change -5.13%
Chart period: 2018-12-24 - 2019-03-22
VOLUME
Buy
TREND
Buy

MV LONG
Buy

MV SHORT
Sell

PIVOT
Sell

MACD
Buy

Will AGRX stock price go up or down on Mon, 25 Mar 2019?

Agile Therapeutics Forecast and Stock Analysis

Technical AGRX stock analysis for March 22, 2019.

Hold candidate since 2019-03-22
Shorts n/a
Cash n/a
Loans n/a
Beta 0.36
ROA -54.20

Agile Therapeutics fell by -5.13% in the last day from $1.56 to $1.48 and has now fallen 9 days in a row. The price has fallen in 8 of the last 10 days , but is still up by 29.82% over the past 2 weeks. Volume has increased in the last day by 101 045 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 414 069 shares bought and sold for approximately $612 822.00.

Close price at the end of the last trading day (Friday, 22nd Mar 2019) of the AGRX stock was $1.48. This is 5.13% less than the trading day before Thursday, 21st Mar 2019.

During day the stock fluctuated 8.28% from a day low at $1.45 to a day high of $1.57.

30 day high of the AGRX stock price was $1.70 and low was $0.90.
90 day high was $1.70 and low was $0.55.
52 week high for the Agile Therapeutics - $3.00 and low - $0.23.

Trend

Agile Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 95.16% during the next 3 months and, with 90% probability hold a price between $2.21 and $3.49 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Tuesday March 12, 2019, which indicates further falls until a new bottom pivot has been found. Agile Therapeutics gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's". Agile Therapeutics holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $1.58. On a fall, the stock will find some support from the long-term average at approximately $1.14. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock holds a RSI14 at 71 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Agile Therapeutics finds support from accumulated volume at $1.44.

Support: $1.44 Price: $1.48 Resistance: $1.62

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.12 between high and low, or 8.28%. For the last week, the stock has had a daily average volatility of 5.45%.

Our recommended stoploss: $1.37 (-7.43%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 71 and this increases the risk substantially. There is a sell signal from pivot top found 8 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation: Hold/Accumulate

Agile Therapeutics holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Hold/Accumulate.

Previous Hold Today AGRX ranks #1181 as HOLD CANDIDATE. Next Hold
Today AGRX ranks #1181 as HOLD CANDIDATE.